Researchers have found in a new study that among patients with chronic kidney disease, non–high-density lipoprotein cholesterol and remnant cholesterol were more consistently associated with atherosclerotic cardiovascular disease risk than…
Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in revenue in 2024.
SEC filings show that, at least for some drugmakers, "most-favored nation" drug pricing deals with President Trump last three years.
People who work at night have a higher risk of coronary artery disease, a type of heart disease. A new study suggests that a higher fibre intake in the diet…
Researchers have found in a new study that Poly-L-lysine (PLL)–coated urinary catheters are safe, well-tolerated, and noninferior to noble metal alloy (NMA)–coated catheters in preventing bacteriuria among adults requiring short-term…
A new study published in The New England Journal of Medicine showed that Fremanezumab reduced migraine and headache days more than a placebo in children and adolescents with episodic migraine.…
A new study published in the Journal of the American Medical Association showed that for juvenile dermatomyositis (JDM), a combination of intermittent intravenous methylprednisolone pulse and mycophenolate mofetil (MMF) may…
The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated positive efficacy and safety outcomes. The trial successfully met its primary endpoint, with patients achieving…
USA: Researchers have found in a recent study that long-term opioid therapy (LTOT) is associated with a modestly increased risk of dental infections. The association, reported in PLOS One, suggests…
Turkey: The year 2025 marked a turning point in dyslipidaemia research, with major advances reshaping how lipid-related cardiovascular risk is understood and managed. In a viewpoint published in the European…